...
首页> 外文期刊>The Internet Journal of Anesthesiology >Intermittent Thoracic Epidural Administration of Ropivacaine-Fentanyl versus Bupivacaine-Fentanyl after Thoracotomy
【24h】

Intermittent Thoracic Epidural Administration of Ropivacaine-Fentanyl versus Bupivacaine-Fentanyl after Thoracotomy

机译:罗哌卡因-芬太尼与布比卡因-芬太尼经胸廓切开术间歇性胸膜硬膜外给药

获取原文

摘要

Background: Pain relief after thoracotomy can be achieved with thoracic epidural analgesia. The pharmacodynamic profile of ropivacaine was reported to be superior to that of bupivacaine, especially in clinical settings where motor block is undesired. We aimed to compare intermittent thoracic epidural analgesia after thoracotomy using either bupivacaine – fentanyl or ropivacaine – fentanyl. Hemodynamics, ventilation, analgesia and side effects were compared..Methods: After general Anesthesia, 30 patients were randomly allocated to receive intermittent epidural bupivacaine 0.25% plus fentanyl 5 μg/ml (n = 15) or ropivacaine 0.25% plus fentanyl 5 μg/ml (n = 15). Heart rate, mean arterial blood pressure, respiratory rate, arterial blood gases were recorded. Motor power, pain score, analgesic requirements and side effects were evaluated over 24 hours postoperatively.Results: Heart rate, arterial blood pressure, respiratory rate and PaCO2 did not show any between-group differences. At8 and 12 hours in the recovery room, arterial O2 tension was significantly higher in RF group than in BF group, with respective values of 141 (29) mm Hg vs. 122 (26) mm Hg and 138 (22) mm Hg vs. 116 (19) mm Hg (P <0.05). Analgesia and diclofenac requirements were comparable in both groups. Motor power of the upper limbs was preservedin both groups. The incidence of side effects did not significantly differ between the two groups.Conclusion: Ropivacaine–fentanyl thoracic epidural analgesia after thoracotomy is comparable to bupivacaine – fentanyl analgesia in terms of pain control and side effects. Introduction Analgesia after thoracic surgery is of utmost importance. Thoracotomy with its noxious insult contributes to postoperative pulmonary dysfunction (1, 2). Epidural administration of local anesthetics and opioids has been used for post-thoracotomy pain relief (2,3,4). Studies on animals (5, 6) and humans (7, 8) revealed that ropivacaine produces less motor block and less cerebral and cardiotoxic effects than bupivacaine. Epidural ropivacaine produced comparable motor block with bupivacaine during labor (8, 9). However, adding opioid to these local anesthetics demonstrated equal analgesic potency with decreased motor block with ropivacaine-opioid (10, 11). In a clinical setting like thoracotomy, it is pertinent to assure good postoperative analgesia without cardiorespiratory compromise. Epidural ropivacaine-fentanyl may be a better choice than bupivacaine-fentanyl in patients subjected to thoracotomy. To test this hypothesis, we randomly allocated patients subjected to lobectomy to receive intermittent epidural ropivacaine-fentanyl or bupivacaine – fentanyl and blindly observed postoperative analgesia, analgesic requirements, cardio–respiratory variables and side effects. Patients and methods This double-blind study was carried out on thirty one adult patients of either sex. Patients undergoing elective lobectomy under posterolateral muscle cutting, rib retraction thoracotomy were the subject of this study. Approval of the Hospital Research Ethics Committee and informed written consent from all patients were obtained. Patients with known contraindications for epidural analgesia, namely patient refusal, infection at the injection site, bleeding diathesis or neurological disorders, were excluded from the study. Patients with diabetes mellitus and those below 18 years were also excluded. Preoperative evaluation of patients included medical history, clinical examination, routine investigation and chest X-ray. Patients received oral diazepam, 10 mg, and two hours before surgery. After arrival to the operative theatre, an intravenous cannula was inserted and lactated Ringer's solution, 1000 ml, was infused over 30 minutes. Monitoring was established with 3-lead ECG, pulse oximetry and capnography. A radial artery catheter was introduced for serial arterial blood sampling and direct arterial blood pressure monitoring. Perioperative heart rate, mean arterial
机译:背景:开胸手术后疼痛可以通过胸膜硬膜外镇痛来实现。据报道,罗哌卡因的药效学特征优于布比卡因,特别是在不需要运动阻滞的临床环境中。我们旨在比较使用布比卡因–芬太尼或罗哌卡因–芬太尼开胸术后的间歇性胸膜硬膜外镇痛效果。方法:全身麻醉后,随机分配30例患者接受间歇性硬膜外硬膜外注射0.25%布比卡因加芬太尼5μg/ ml(n = 15)或罗哌卡因0.25%加芬太尼5μg/ ml ml(n = 15)。记录心率,平均动脉血压,呼吸频率,动脉血气。术后24小时评估运动能力,疼痛评分,镇痛要求和副作用。结果:心率,动脉血压,呼吸频率和PaCO2没有显示组间差异。在恢复室中的第8和12小时,RF组的动脉血氧张力明显高于BF组,分别为141(29)mm Hg vs. 122(26)mm Hg和138(22)mm Hg vs. BF。 116(19)毫米汞柱(P <0.05)。两组的镇痛和双氯芬酸需求量相当。两组均保留上肢运动动力。两组之间的副作用发生率无显着差异。结论:开胸后罗哌卡因-芬太尼胸膜硬膜外镇痛的疼痛控制和副作用与布比卡因-芬太尼镇痛相当。引言胸外科手术后的镇痛至关重要。开胸手术及其有害的伤害会导致术后肺功能障碍(1、2)。硬膜外给药局麻药和阿片类药物已用于开胸术后的疼痛缓解(2,3,4)。对动物(5、6)和人类(7、8)的研究表明,罗比卡因比布比卡因产生更少的运动阻滞,对脑和心脏的毒性也较小。硬膜外罗哌卡因在分娩过程中产生了与布比卡因相当的运动阻滞(8、9)。然而,在这些局部麻醉药中添加阿片类药物显示出与罗哌卡因-阿片类药物相同的镇痛效果,并减少了运动阻滞(10、11)。在开胸手术等临床环境中,有必要确保良好的术后镇痛效果而不会影响心肺功能。在开胸手术中,硬膜外罗哌卡因-芬太尼比布比卡因-芬太尼可能是更好的选择。为了验证这一假设,我们随机分配接受肺叶切除术的患者接受间歇性硬膜外罗哌卡因-芬太尼或布比卡因-芬太尼的治疗,并盲目观察术后镇痛,镇痛要求,心肺功能和副作用。患者和方法这项双盲研究是针对31位男女成年患者进行的。本研究的对象是在后外侧肌肉切割下进行选择性肺叶切除,肋骨后退开胸术的患者。获得医院研究伦理委员会的批准并获得所有患者的知情书面同意。该研究排除了具有硬膜外镇痛禁忌的已知禁忌症的患者,即患者拒绝服药,注射部位感染,血液透析或神经系统疾病。糖尿病患者和18岁以下的患者也被排除在外。患者的术前评估包括病史,临床检查,常规检查和胸部X光检查。患者在手术前两个小时接受口服安定10 mg。到达手术室后,插入静脉套管,并在30分钟内注入1000毫升乳酸林格氏液。用3导联心电图,脉搏血氧饱和度和二氧化碳图建立监测。引入radial动脉导管以进行系列动脉血取样和直接动脉血压监测。围手术期心率,平均动脉

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号